MG217 Psoriasis Therapeutic Scalp Treatment

MG217 Psoriasis Therapeutic Scalp Treatment is an FDA-registered drug product whose active ingredient is COAL TAR. It is labelled by Wisconsin Pharmacal Company taken by topical and marketed as a human otc drug product. Identifiers on file: NDC 68093-5206, application part358H, label effective 20181210. It is one of 7 FDA drug label records sharing the active ingredient COAL TAR. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.

Across FDA labelling, products containing COAL TAR are most often described in connection with: temporary relief, symptoms associated, psoriasis seborrheic, dermatitis dandruff, itching scaling, flaking redness, irritation ofthe, scalp helps. Wording differs between labels, and the full indications section on this page takes precedence when it is present.

Uses For the temporary relief of these symptoms associated with psoriasis, seborrheic dermatitis or dandruff itching scaling flaking redness irritation ofthe scalp. Helps prevent recurrence.

Directions shake well before using. wet hair then massage liberal amount of MG217 into the scalp and leave on for several minutes. Rinse thoroughly. for best results, use at least twice a week or as directed by a physician.

Warnings For external use only. Ask doctor before use if condition covers a large area of the body. When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water. use caution in exposing skin to sunlight. It may increase your tendency to sunburn for up to 24 hours after application. do not use with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs unless directed by a physician. do not use for prolonged periods without consulting a physician. Stop use and ask a doctor if condition worsens. condition does not improve after regular use of this product as directed. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately. WARNING This product can gose you to chemicals including Coal Tar, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov

FDA lists 7 drug label records with COAL TAR as the active ingredient. The most common dosage forms and the manufacturers with the most records are summarised below; strengths, pack sizes and inactive ingredients can still differ between apparently similar products.

3 FDA recall record(s) match this product name or manufacturer. A match means the firm or product name appears in the enforcement report; confirm lot numbers and dates against the official FDA notice before acting.

What is MG217 Psoriasis Therapeutic Scalp Treatment used for?
Uses For the temporary relief of these symptoms associated with psoriasis, seborrheic dermatitis or dandruff itching scaling flaking redness irritation ofthe scalp. Helps prevent recurrence.

Who makes MG217 Psoriasis Therapeutic Scalp Treatment?
Wisconsin Pharmacal Company is the labeler of record for MG217 Psoriasis Therapeutic Scalp Treatment. 7 FDA label records share the active ingredient COAL TAR, so generic and branded versions may come from different companies; the manufacturer named on your pack is the one that matters for any enquiry.

What form does MG217 Psoriasis Therapeutic Scalp Treatment come in?
administered by topical. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.

Is MG217 Psoriasis Therapeutic Scalp Treatment prescription or over-the-counter?
The FDA label for this product is recorded as human otc drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.

Are there other products containing COAL TAR?
Yes. 7 FDA drug label records list COAL TAR as the active ingredient. Products with the same active ingredient can usually be substituted only when a prescriber or pharmacist confirms it is appropriate.

Has MG217 Psoriasis Therapeutic Scalp Treatment been recalled?
3 FDA recall record(s) match this product name or manufacturer. Review the recall and safety notices section on this page and confirm lot numbers against the official FDA enforcement report.

Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.